Form 4: Boston Scientific Director Sells Shares in Recent Transaction

A Boston Scientific director, Edward J. Ludwig, sold 4,877 shares of common stock at a price of $91.6346 per share on November 21, 2024.

Summary

• Edward J. Ludwig, a director at Boston Scientific Corp, sold 4,877 shares of the company's common stock on November 21, 2024.
• The sale was executed at a price of $91.6346 per share.
• Following the transaction, Mr. Ludwig directly owns 39,398 shares of Boston Scientific common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing for an insider stock sale, which is neither positive nor negative in itself. It's a neutral event.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The sale by a director is a common occurrence and does not necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The stock sale by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect on the company's operations or other stakeholders.

Key Dates

Keywords

Boston Scientific, BSX, stock sale, insider trading, director, Edward J. Ludwig, share transaction